Stability Benchmarking: When Heat Becomes the Enemy

Temperature is the silent killer of viral RNA. From a swab taken in a summer field clinic to a package delayed on a tarmac, the thermal journey of a sample is rarely smooth.

We tested HCY’s VTM across three temperature conditions: refrigeration (4°C), room temperature (25°C), and thermal stress (37°C). Viral RNA degradation curves were plotted at 24-hour intervals for seven days.

The results were striking. At 4°C and 25°C, RNA integrity remained above acceptable thresholds for the full seven days. But the real revelation came at 37°C—a temperature that simulates extreme summer transport conditions. Even under this stress, HCY’s VTM maintained viral RNA with no significant degradation for up to seven days.

To put this in perspective, many commercial VTMs begin showing RNA decay within 48 to 72 hours at 37°C. A seven-day window at high temperature is not common. It is the result of a carefully balanced formulation that stabilizes nucleic acids far longer than industry norms require.

Bacterial and Fungal Inhibition: The Hidden Variable

A contaminated sample is a wasted sample. When bacteria or fungi overgrow in transport media, they can degrade viral RNA, consume nutrients, or trigger false positives in PCR assays. Yet many VTMs treat contamination as an afterthought.

We tested HCY’s VTM by inoculating samples with high microbial loads—levels far exceeding what would be expected in routine clinical swabs. The medium’s antibiotic and antifungal combination was then evaluated for inhibitory performance over 24 hours.

The data speaks for itself. Within 24 hours, microbial contamination was suppressed by 99.9%. This level of inhibition does more than protect sample integrity. It directly reduces the risk of false positives in PCR workflows and prevents culture failures in laboratories that rely on viral isolation.

For labs processing hundreds of respiratory samples daily—especially during flu season when co-infections are common—this margin matters. A 99.9% inhibition rate means one contaminated result in every thousand samples. Without it, the rate can climb to dozens per day.

Platform Compatibility: The Integration Imperative

A VTM does not work alone. It sits upstream of extraction robots, PCR thermocyclers, and multiplex assays from multiple manufacturers. Incompatibility—even subtle—can degrade performance at the final step.

We validated HCY’s VTM against a broad panel of mainstream PCR reagent kits and automated extraction platforms, including systems from Roche, Abbott, Thermo Fisher Scientific, Qiagen, and Hologic.

In every case, the VTM demonstrated seamless integration. No extraction inefficiencies. No PCR inhibition. No reagent incompatibility.

This compatibility is not accidental. As a long-standing OEM supplier to many of the world’s top IVD companies, HCY has engineered its VTM formulation to align with the workflows and chemistry profiles that dominate the global diagnostic landscape. The result is a system that works with over 95% of major detection platforms—not as a compromise, but by design.

Conclusion: Benchmarking Separates Promise from Proof

Stability under heat. Suppression of contamination. Compatibility across platforms. These are not abstract quality metrics. They are the measurable, repeatable benchmarks that distinguish a high-performance viral transport system from a commodity tube.

Our internal studies show that HCY’s VTM meets or exceeds international standards in all three categories. But we do not ask you to take our word for it. The data exists. The benchmarks are replicable. And any laboratory with the right equipment can verify them independently.

That is what benchmarking is for: to separate promise from proof. And by that measure, HCY’s VTM stands at the international front line.

Interested in the full benchmark data set or custom validation for your platform? Contact our technical team for detailed reports and sample testing.

Criterion One: The Regulatory Triple Lock

In a global market flooded with unbranded and unverified collection kits, regulatory clearance is not just paperwork; it is the ultimate stress test.

True high-performance VTMs don’t just claim quality—they prove it through the world’s most stringent regulatory frameworks. Achieving China NMPA, US FDA 510(k) clearance, and EU CE MDR certification simultaneously is remarkably rare. Each pathway demands rigorous validation: stability studies, biocompatibility tests, and clinical performance data that most manufacturers simply cannot produce.

In the complex global regulatory landscape, only a handful of manufacturers hold all three credentials. HCY Technology is one of them. For laboratories and procurement teams, this triple lock isn’t just a badge of honor—it’s the elimination of compliance risk before a single sample is collected.

Criterion Two: The Art of Keeping Viruses Alive (or Safely Inactivated)

Not all VTMs are created equal—and the choice between non-inactivating and inactivating formulations is just the beginning. Performance is measured in hours, degrees, and recovery rates.

A truly high-performance VTM does two things exceptionally well. First, it maintains viral integrity during transport. For non-inactivating formulations, this means preserving the virus’s structural integrity for downstream applications like viral culture. Second, it keeps bacterial and fungal contaminants in check, preventing overgrowth that can trigger false positives or degrade RNA.

The numbers matter here. In validated systems, viral RNA remains stable at 2–8°C for over 48 hours, with recovery rates exceeding 90% for common respiratory viruses such as influenza A and B. Beyond stability, the medium’s composition—balanced salt solutions, protein stabilizers, and precise antibiotic concentrations—determines whether a sample arrives at the lab intact or compromised.

HCY’s patented VTM formulation has been refined specifically to meet the demands of both PCR diagnostics and viral culture workflows—a combination that many laboratories consider the gold standard when evaluating VTM performance.

Criterion Three: The Physics of Collection

The swab itself is often underestimated. Yet, in viral transport, the surface area and release efficiency of the swab directly impact whether a sample yields a detectable result.

Conventional cotton or rayon swabs trap cells within their fibers, releasing only a fraction of the collected material into the transport medium. Flocked swabs, by contrast, are engineered with short, perpendicular fibers that act like a micro-brush. They capture cells across their entire surface and—crucially—release them efficiently into the medium through capillary action.

This is not a minor detail. Studies consistently show that flocked swabs deliver significantly higher cell yields compared to traditional alternatives. For low-viral-load patients, that difference can mean the line between detection and a missed diagnosis.

Conclusion: Excellence Is Not a Claim—It’s a Composite

High-performance viral transport is not the result of a single feature. It is the convergence of three elements: regulatory rigor that proves reliability, a formulation that preserves or stabilizes with precision, and a swab design engineered for maximum yield.

These are the unspoken criteria—the factors that separate products built for diagnostics from those simply filling a catalog. When a VTM system quietly meets all three, it does something remarkable: it removes uncertainty from the very first step.

And in diagnostics, removing uncertainty is what excellence looks like.

1. Core Purpose & Functions

VTM solves the inherent fragility of viruses (non-living, sensitive to pH, temperature, drying, and enzymes). Its main roles:

• Prevent desiccation: Keeps samples moist to avoid viral particle breakdown.
• Stabilize pH: Maintains neutral pH (~7.2–7.4) to protect viral structure.
• Inhibit contaminants: Contains antimicrobials to stop bacteria/fungi overgrowth.
• Preserve viral material: Either maintains infectious viability (for culture) or protects nucleic acid (RNA/DNA) (for PCR/NAAT).
• Enable safe transport: Reduces biohazard risk (inactivated VTM).

2. Key Components & Roles

Standard VTM is an isotonic buffered solution with these essential ingredients:

表格

3. Types of Viral Transport Media

A. Viable (Infectious) VTM

• Purpose: Preserve live virus for virus isolation/culture.
• Features: No lysis agents; nutrients + stabilizers; must stay 2–8°C (refrigerated).
• Use: Research, surveillance, antiviral susceptibility testing.

B. Inactivated (Nucleic Acid) VTM

• Purpose: Lyse virus instantly (kills infectivity) but stabilizes viral RNA/DNA.
• Features: Contains guanidine HCl/guanidine thiocyanate.
• Advantage: Safe handling; stable at room temperature; ideal for PCR/NAAT.
• Use: Clinical diagnostics (COVID-19, influenza, RSV).

C. Universal Transport Medium (UTM)

• All-in-one: Works for viruses, chlamydia, mycoplasma, ureaplasma.
• Commonly used in clinics for broad respiratory/STI testing.

4. Common Clinical Applications

VTM is used for swabs/specimens from:

• Respiratory: Nasopharyngeal (NP), nasal, throat swabs (COVID-19, flu, RSV, adenovirus)
• Ocular: Conjunctival swabs (HSV, adenovirus)
• Genital: Urethral, cervical swabs (HSV, HPV, chlamydia)
• Cutaneous: Vesicle/lesion swabs (VZV, HSV)
• Stool: Enteric viruses (rotavirus, norovirus)
• Blood/CSF: For viremia/neurotropic viruses

5. Storage & Transport Conditions

• Short-term (0–48h):
  • Viable VTM: 2–8°C (refrigerated) — DO NOT FREEZE
  • Inactivated VTM: Room temp (15–30°C) or 2–8°C
• Long-term:
  • Viable: −70°C to −80°C (freezer)
  • Inactivated: Up to 1 week at 2–8°C; months at −20°C
• Critical: Avoid repeated freeze–thaw cycles.

6. Advantages of Using VTM

• Maintains sample integrity → higher test sensitivity/accuracy.
• Reduces contamination → fewer false results.
• Flexible temp stability → easier logistics.
• Safe: Inactivated forms lower infection risk.
• Compatible: Works with PCR, antigen tests, and culture.

7. How to Use VTM (Standard Protocol)

1. Collect specimen with a flocked swab (Dacron/rayon) (not cotton/wooden).
2. Place swab fully into VTM tube; break/remove stick; cap tightly.
3. Label clearly: patient ID, date, sample type, test requested.
4. Store/transport at correct temp (2–8°C or RT).
5. Deliver to lab within 24–48h for best results.

8. Common Misuses & Pitfalls

• ❌ Using bacterial transport media (e.g., Cary-Blair) for viruses → viral death.
• ❌ Freezing viable VTM → ice crystals destroy virus.
• ❌ Delayed transport >48h → viral degradation.
• ❌ Leaky tubes → contamination + biohazard.
• ❌ Cotton/wood swabs → toxic to some viruses.

9. VTM vs. UTM vs. Normal Saline

• Normal Saline: No buffers/antimicrobials → only immediate testing (≤1h)PMC.
• VTM: Optimized for viruses.
• UTM: Universal for viruses + chlamydia + mycoplasma.

10. Summary

Viral Transport Media is essential for reliable viral diagnostics. Choose inactivated VTM for routine PCR (safe, room-temp stable) and viable VTM only when virus culture is needed. Always follow temperature and timing guidelines to preserve sample quality.

In this high-pressure environment, having a sample collection and transport system that performs consistently—across multiple virus types—isn’t just a convenience. It’s a necessity.

Beyond COVID-19: A Universal Solution for Respiratory Surveillance

While viral transport media (VTM) became a familiar term during the COVID-19 pandemic, its role has always been broader. HCY’s VTM is designed as a universal solution for multi-virus surveillance, supporting not only SARS-CoV-2 but also Influenza A, Influenza B, Respiratory Syncytial Virus (RSV), adenovirus, rhinovirus, and other common respiratory pathogens.

This versatility means laboratories can standardize their collection workflow without the need for virus-specific kits—reducing complexity, minimizing storage requirements, and streamlining operations during peak seasons.

The science behind it matters. In FDA 510(k) documentation, HCY’s VTM has demonstrated viral recovery rates exceeding 70%, a key benchmark for transport medium stability. These validation data confirm that the system preserves nucleic acid integrity across a range of viral targets, helping to ensure that what reaches your molecular diagnostics platform is accurate and reliable—from collection to analysis.

Supply Chain You Can Trust

Seasonal surges don’t wait for supply chains to catch up. HCY’s ability to scale matters most when demand spikes. With a 15,000-square-meter manufacturing facility and 17 years of experience in the industry, HCY maintains the production capacity and logistical infrastructure to support large-scale public health needs. Whether for routine monitoring or unexpected outbreaks, the supply chain is built to deliver—consistently, and at volume.

Designed for the Lab, Built for Efficiency

Beyond performance and availability, the details make a difference in day-to-day lab operations. HCY’s VTM kit is designed with practical features that support efficiency:

• Flocked swabs with a pre-scored breakpoint —enabling clean, consistent separation from the handle after sample collection.
• Leak-proof screw caps —engineered to prevent leakage during transport, reducing contamination risks and sample loss.
• Conical, self-standing tubes —allowing for easy centrifugation and streamlined pre-analytical handling.

These design elements, while straightforward, help reduce handling time and variability—especially valuable when processing hundreds or thousands of samples per day.

A Reliable Partner for Respiratory Surveillance

As the next flu season approaches, preparedness goes beyond stocking supplies. It means choosing tools that perform reliably across viruses, scale with demand, and support the efficiency that high-volume testing requires.

For public health laboratories, clinical diagnostic centers, and surveillance networks, HCY’s VTM offers a straightforward, proven option—one built to handle the season’s challenges, no matter which viruses are circulating.

Remember the early days of the pandemic, when testing supplies were so scarce that hospitals resorted to making their own viral transport media in veterinary school labs?  It was a desperate time. Supply chains choked, prices soared, and somewhere in the chaos, a simple question got lost: Did we really need all that fancy VTM?

The short answer might surprise you. According to multiple peer-reviewed studies, plain old 0.9% sterile saline—the same stuff in $2 IV bags—performed nearly identically to commercial viral transport media in COVID-19 PCR testing .

Let that sink in for a moment.

The Data That Changes Everything

In a 2020 study published in the Indian Journal of Medical Research, scientists did what scientists do best: they questioned authority with pipettes. They took 135 samples, split them between commercial VTM and sterile normal saline, and ran the numbers .

The results? A mean Ct value difference of just 0.46 cycles.

For those who don’t speak PCR, that’s statistically insignificant. The sensitivity clocked in at 97.1%, with 100% specificity . Translation: saline caught the virus just as well as the expensive stuff.

A separate study published in PLOS ONE went further, testing samples stored at multiple temperatures across seven days. Their conclusion was almost irritating in its simplicity: normal saline, PBS, and commercial VTM all showed “comparable performance in maintaining virus integrity and stability” . Even at room temperature. Even at 37°C .

And here’s the kicker: another research team found that samples in saline stored at ambient temperature actually showed slightly lower Ct values after 48 hours than those in VTM (28.29 vs. 30.02) . In virology, lower Ct means more detected virus.

So… Have We Been Scammed by Big VTM?

Not so fast.

If saline works so well, why did labs worldwide scramble for “proper” transport media? Why did the FDA update emergency guidelines to allow alternatives only when supplies ran low? 

The answer is more nuanced than conspiracy.

What VTM Actually Does

Viral transport media isn’t magic. It’s essentially a buffered salt solution (Hanks Balanced Salts, if you want the recipe) spiked with three critical ingredients :

1. Proteins (usually fetal bovine serum) to stabilize the virus
2. Antibiotics to kill bacteria that would otherwise overgrow and confuse results
3. pH indicators (that pink phenol red) to show if the sample has gone bad

Saline has none of these. It’s just salt water. Sterile, cheap, and dumb as a rock.

When Saline Works

For molecular testing—PCR, which looks for viral RNA—saline is perfectly adequate. RNA is surprisingly tough, and multiple studies confirm that it survives just fine in simple salt water for days . The Kenyan study using cultured SARS-CoV-2 found detectable virus in saline for a full week, even at tropical temperatures .

When Saline Fails

Here’s the catch most headlines miss: PCR isn’t the only test.

If you need to culture live virus—for research, vaccine development, or antiviral testing—saline is useless. No proteins means the virus falls apart. No antibiotics means bacterial overgrowth. No buffer means pH swings that finish the job .

And if you’re storing samples for months? Saline won’t cut it. The long-term preservation game requires the full VTM cocktail.

The Real Story: Horses for Courses

What the pandemic revealed isn’t that VTM is a scam. It’s that we were using Ferrari-grade media for grocery-store trips.

For routine diagnostic PCR—which constituted 99% of COVID testing—saline would have worked. Should have worked. Did work, whenever anyone bothered to test it .

But here’s the uncomfortable truth: nobody wants to be wrong.

If a lab uses saline and a sample degrades (unlikely, but possible), that’s on them. If they use gold-standard VTM and a sample degrades, well, that’s the virus’s fault. In medicine, defensive practices drive supply chains as much as science does.

Where We Land: The Case for Huachenyang

So, should you just grab a bag of IV saline and call it a day?

No. But also, maybe yes.

Here’s the practical reality: if you’re running a high-throughput lab with cold chain transport, stable storage conditions, and same-day processing, saline is a perfectly defensible choice. The data backs you up .

But if you’re shipping samples across continents? If you’re storing them for weeks? If you need the option to culture later? If you want zero ambiguity about sample integrity?

You want proper VTM.

And this is where Huachenyang enters the conversation.

The Huachenyang Difference

Our viral transport media isn’t expensive because we like charging more. It’s expensive because it contains what saline doesn’t:

• Optimized protein stabilization that keeps viruses intact from collection to analysis
• Broad-spectrum antibiotics that suppress bacterial and fungal growth even in poorly collected samples
• Precision buffering that maintains pH across temperature swings from -80°C to tropical heat
• Quality control you can trace—every batch tested, certified, and documented

The studies proving saline works were conducted under ideal conditions: known positive samples, immediate processing, controlled environments . Real-world testing involves couriers leaving samples in hot trucks, variable collection quality, and delays.

Huachenyang VTM is insurance. It’s the difference between “probably fine” and “definitely accurate.”

The Smart Strategy

Here’s what we tell our clients:

• For routine surveillance with rapid transport and controlled conditions? Consider validated alternatives. The science supports it.
• For clinical diagnosis where results change treatment? Use validated VTM.
• For research samples destined for biobanks? Absolutely use VTM.
• For remote collection with uncertain transport? Don’t gamble. Use VTM.

The Bottom Line

Were we “held hostage” by expensive VTM during the pandemic? Not exactly. But we were certainly victims of default thinking—the assumption that “gold standard” means “only standard.”

The research is clear: sterile saline works for PCR detection of SARS-CoV-2. The sensitivity is there. The stability holds. At 4°C, at room temperature, even at 37°C .

But “works” isn’t the same as “optimal.” And when you’re dealing with infectious diseases, patient results, and public health decisions, optimal matters.

Huachenyang VTM exists for the moments when “good enough” isn’t good enough. When you need certainty. When you need flexibility. When you need to know, without doubt, that the sample arriving at your lab represents the patient who gave it.

Saline is a tool. VTM is a system. Choose based on what you’re building.

Want to talk through your specific workflow? Our lab scientists actually answer the phone. Contact Huachenyang for a consultation—no sales pitch, just straight talk about what your samples actually need.

For manufacturers like Huayangyang, and for the healthcare providers who rely on our sampling devices, the conflict flaring in the Middle East isn’t just a geopolitical headline—it is a direct hit on the supply chain. It is a war premium stamped onto every kilogram of plastic resin and every liter of chemical reagent.

The Anatomy of a Price Spike

To understand why your budget for sampling swabs, VTM kits, and CHG applicators is suddenly under pressure, we have to look at the raw materials before they become medical devices.

Our swab handles and vial bodies are primarily derived from Polypropylene (PP) and Polyethylene (PE). These are the workhorses of the plastics industry. But you cannot mine polypropylene out of the ground; it is born from crude oil and naphtha.

Right now, that birth is extremely expensive.

The recent closure of the Strait of Hormuz has effectively severed a major artery of global petrochemical supply . This narrow waterway handles about one-fifth of the world’s oil supply and a significant portion of liquefied natural gas . As tanker traffic ground to a halt, Brent crude briefly shattered the $114 per barrel mark .

Here is the math that keeps procurement managers up at night: When oil surges, naphtha (the refined product) follows immediately. Data from early March showed naphtha costs jumping to multi-month highs, climbing nearly 34% since late 2025 . This has caused an “abrupt repricing” of polyolefins (like PP and PE) across Asia, with sellers either yanking offers off the table or issuing new ones at dramatically higher rates . In China, the market saw the kind of volatility rarely seen in peacetime, with polyethylene (PE) premiums spiking over 1,600 points above futures .

The Hidden Chemistry of a “Simple” Kit

The plastic, however, is only half the story. The cost pressures on the liquid inside our products are just as severe.

1. VTM (Viral Transport Medium): The stability of a VTM depends on a cocktail of amino acids, antibiotics, and buffers. These are fine chemicals, and their synthesis is incredibly energy-intensive. As the price of feedstock rises, chemical giants are forced to pass on those costs or declare force majeure. Reports indicate that the methanol market—critical for many synthesis processes—has been directly impacted by the Strait closures, with Asian prices surging as over 50% of the region’s imports face delays .

2. CHG Applicators: Chlorhexidine Gluconate, the active ingredient in our disinfectant applicators, relies on a complex chemical supply chain. With the conflict disrupting benzene and propylene supplies , the intermediate chemicals required for synthesis are becoming scarcer by the day.

“Sit Back and Wait” is Not a Strategy

The current market behavior is best described as “defensive positioning” . Converters and manufacturers are no longer buying for next month; they are scrambling to secure near-term coverage at any cost.

This has created a bizarre trading environment. “Manufacturers and traders are suspending offers,” noted analysts covering the Asian polymer markets. In India, packaging costs—which use similar materials to medical devices—have already jumped by more than 20% . We are seeing suppliers refuse to quote fixed prices, moving to “daily pricing” models to hedge their own risks . For a medical device manufacturer, this level of uncertainty is the real enemy. It makes long-term contracts with hospitals nearly impossible to price.

The Long View: Why This Isn’t Just a “Blip”

There is a temptation to view this as a temporary spike. Historically, when the shooting stops, prices normalize.

However, many industry analysts suggest this time feels different. Even if the Strait of Hormuz reopens tomorrow, the damage to the supply chain has triggered a series of “supply shrinks” that will take months to unwind. Crackers (the facilities that turn naphtha into plastic building blocks) in Japan and South Korea have been forced to reduce operating rates due to a lack of feedstock . In Singapore and Thailand, plants have declared force majeure .

It takes weeks to restart a paused cracker. It takes months to untangle a logistics chain. And it takes years to rebuild the inventory buffers that were drained during the initial shock.

Navigating the Storm

At Huayangyang, we are facing this head-on. The cost of the polypropylene for our swab sticks is rising. The cost of the stabilizers in our VTM is rising. The cost of the gas required to ship it all is rising.

While we cannot control the price of oil in Tehran or the shipping lanes in the Gulf, we are committed to transparency. We are actively working to secure alternative feedstock sources and optimizing our production lines to mitigate the impact on our partners.

We believe in keeping the supply chain for global health moving, no matter the headwinds. In the coming weeks, we will continue to provide updates on how these market forces are shaping our industry.

Stay tuned to this space for more insights into the forces driving the medical supply chain.

At Huachenyang, we understand the critical balance between these two priorities. Our mission is to provide solutions that ensure absolute safety for handlers without compromising the integrity of the viral nucleic acid required for reliable qPCR detection. Here is how we bridge the gap.

The Core Difference: Inactivation vs. Preservation

Non-inactivated VTM functions primarily as a preservation solution. Its goal is to maintain the virus in a viable state, protecting it from environmental damage to keep the nucleic acid intact. While this preserves the viral structure, it also means the sample remains infectious, posing a higher risk to laboratory personnel during processing.

Inactivated VTM, on the other hand, is engineered to neutralize the virus immediately upon collection. By destroying the viral lipid envelope, it renders the sample non-infectious, drastically improving safety. However, the chemical agents used for inactivation can sometimes degrade the viral RNA, leading to the common industry concern: “Does inactivation affect my detection rate?”

The Huachenyang Solution: The Power of a Specific Lytic Salt

This is the exact concern we designed our product to address. The key to our Huachenyang Inactivated VTM lies in our proprietary formulation, specifically our use of targeted lytic salts such as Guanidine Isothiocyanate.

Here is how it works:

1. Rapid Inactivation: Guanidine isothiocyanate is a powerful chaotropic agent. It immediately disrupts the lipid membrane of viruses (including enveloped viruses like influenza or coronaviruses). Within minutes of collection, the virus is rendered inactive, protecting healthcare workers and the lab environment.
2. Superior RNA Protection: While it breaks the virus apart, Guanidine isothiocyanate is also one of the best-known agents for protecting nucleic acids. It creates a chemical environment that instantly denatures nucleases (RNases and DNases)—enzymes that would otherwise chop up the viral RNA. By neutralizing these enzymes, the formulation ensures the viral RNA is “frozen in time” and preserved exactly as it was upon collection.
3. Room Temperature Stability: This protection is robust. Unlike standard saline solutions that may require immediate refrigeration, the chemical environment in our VTM stabilizes the nucleic acid, preventing degradation even during room temperature transport and storage.

Why This Matters for Your PCR Results

By using Guanidine isothiocyanate, we achieve the perfect equilibrium:

Integrity: The viral RNA remains intact, abundant, and ready for extraction. Because the nucleic acid is protected from the moment of collection, the Ct values in your qPCR remain reliable and representative of the original patient sample.

Safety: The sample is non-infectious, allowing for safe handling in BSL-2 laboratories without the need for immediate, high-level containment protocols.

Choosing the Right Tool for the Job

While our inactivated VTM offers the best balance of safety and stability, we recognize that different applications require different tools:

• Huachenyang Inactivated VTM is ideal for routine PCR testing where lab safety and high throughput are priorities. It eliminates the infectious risk and allows for flexible logistics.
• Huachenyang Non-Inactivated VTM is recommended when viral culture is required downstream. For applications solely focused on genetic analysis, our inactivated formula provides the superior choice.

Conclusion

At Huachenyang, we don’t believe you should have to choose between the safety of your team and the accuracy of your results. Our Inactivated VTM, powered by a precise lytic salt formulation, ensures that viruses are neutralized instantly while their genetic blueprints are preserved perfectly.

With Huachenyang, you can collect samples confidently, transport them securely, and amplify them accurately.

Virus Transport Medium OP Kit

VTM Kits are stored at room temperature with a shelf life of 24 months

Application:
For clinical influenza, avain influenza (such as H7N9), hand-foot-mouth disease, measles and other virus samples such as mycoplasma, urea plasma, chlamydia collection and transportation.

Ingredients:
Water, Sucrose, Glycerol (substance with a Community workplace exposure limit), Sodium Chloride, 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, sodium salt, hydrate (2:6:11), Sodium N-lauroylsarcosinate, Phenol Red, Glucose

For in vitro diagnosis only. Wear gloves and masks when collecting. Do not touch swab if the swab tip came into contact with transport media. Do not use if expired, turbid, or leaking. Do not use if any damage occurs to the package.

Specifications of Non-inactivated Viral Transport Medium

We offer a variety of sample collection tubes, including FDA-approved tubes, saline solution tubes, VTM tubes, and AMIES tubes. Please contact the factory for more information.

Features and Benefits
Ensure the stability and viability of viruses, chlamydia, and mycoplasma.
Manufactured based on CDC formula.
Antimicrobic blend suppresses bacterial and fungal contamination.
Supplied in bulk (1 Litre) to provide options for custom applications.
Preserve swab samples for up to 48h when preserved at 2–8°C.
Norgen’s Viral Transport Medium is formulated to transport samples that are presumably infected with a virus. Viral Transport Medium is manufactured based on CDC formula and is offered in bulk to provide an option to readily assemble swab collection devices for sample collection.

HCY’s Viral Transport Medium (VTM) is designed for safe and efficient transport of viral samples, including but not limited to those from nasal, throat, and other swabs. The VTM contains a balanced mix of Hank’s Balanced Salt Solution (HBSS), heat-inactivated fetal bovine serum (FBS), gentamicin sulfate, and amphotericin B to preserve the viability of viruses and prevent the growth of contaminating bacteria and fungi. The medium ensures the stability and viability of viruses, chlamydia, and mycoplasma for analysis using different techniques. In addition, the Viral Transport Medium eliminates the need to immediately process or freeze samples.

The current landscape presents a dual challenge: a highly transmissible virus and strained healthcare resources. The subclade K strain, which accounts for nearly 92% of analyzed flu samples, is notable for its ability to partially evade prior immunity, leading to widespread infection. Concurrently, emergency departments are experiencing increased visits, and vaccination rates—while a vital tool for preventing severe outcomes—remain lower than desired, with only about 130 million doses administered this season.

In this environment, traditional testing pathways—requiring sick individuals to travel to clinics, urgent care centers, or hospitals—pose a significant burden. They increase the risk of exposure for vulnerable patients and healthcare workers and can delay diagnosis and treatment. Timely antiviral treatment for influenza is most effective when started within one to two days of symptom onset, making rapid and convenient testing a key component of effective management.

This is where telemedicine-guided diagnostic solutions and at-home self-sampling emerge as transformative tools for modern healthcare delivery. The pandemic era catalyzed a massive shift toward contactless health care services, proving that remote diagnostic models are not only feasible but also highly satisfactory for users. A 2024 feasibility study published in JMIR Formative Research demonstrated that a comprehensive telemedicine approach for SARS-CoV-2 self-sampling achieved a 95% sample receipt rate and a 76% successful return rate for diagnostics. Users reported high satisfaction with the model’s ease of use and interface. This validated framework provides a ready-made blueprint for addressing the current influenza crisis.

At the heart of any reliable remote testing program is a robust and user-centric sample collection system. This is the domain of the Viral Transport Medium (VTM) kit. For companies like Huachenyang Technology Co., Ltd., specializing in diagnostic specimen collection, this moment represents a critical opportunity to support public health. Our VTM sampling kits are engineered to bridge the gap between the patient’s home and the clinical laboratory with uncompromising integrity.

The core function of a high-quality VTM is twofold: preservation and inactivation. Specimens must remain viable for accurate polymerase chain reaction (PCR) testing, the gold standard for sensitivity and specificity in viral detection. Concurrently, ensuring the virus is inactivated within the medium is crucial for safe transport and handling. Research cited by the National Institute of Standards and Technology (NIST) confirms that certain VTM formulations can completely inactivate high-titre SARS-CoV-2 in as little as two minutes, rendering samples non-infectious and safe for point-of-care processing or transport. This dual capability makes VTM kits indispensable for decentralized testing models.

Our VTM sampling kits are designed with the end-user—often an anxious individual feeling unwell—in mind. Each kit contains clear, pictogram-based instructions and all necessary components: sterile swabs for oropharyngeal or midturbinate sampling, a leak-proof tube containing the optimized VTM, and secure packaging compliant with transport regulations (e.g., UN 3373). The goal is to make the self-collection process intuitive, thereby minimizing user error and ensuring the sample collected at home is as reliable as one collected by a healthcare professional.

The integration pathway is straightforward and leverages existing digital health infrastructure. A patient experiencing flu-like symptoms initiates a consultation via a telehealth platform. If testing is indicated, a Huachenyang VTM kit is dispatched directly to their home. Upon arrival, the patient follows the guided instructions to collect their sample, places it in the pre-labeled transport box, and returns it via mail or a dedicated courier service. The sample is then processed at a partnered clinical laboratory, and results are communicated securely through the platform, often with follow-up care guidance.

This model delivers profound benefits:

• Reduced Burden on Healthcare Systems: It alleviates pressure on crowded clinics and emergency rooms, allowing them to focus on the most severe cases.
• Enhanced Access and Equity: It provides testing access for individuals in remote areas, those with mobility issues, or those without easy transportation.
• Faster Time-to-Treatment: By eliminating travel and waiting room times, it accelerates the diagnostic journey, enabling quicker initiation of antiviral medications like oseltamivir (Tamiflu) when appropriate.
• Improved Public Health Surveillance: Standardized at-home kits facilitate the collection of interoperable, anonymized data that can feed into public health dashboards, offering real-time insights into the spread and evolution of viruses like subclade K.

The evidence for this shift is compelling. Beyond the SARS-CoV-2 study, VTM-based kits have been successfully used in protocols for a range of respiratory virus detection and genomic surveillance studies worldwide. The current U.S. flu season, marked by the rapid spread of a distinct subclade, underscores the urgent need for agile, scalable, and patient-friendly testing solutions that can keep pace with viral evolution.

For healthcare providers, telehealth companies, and corporate wellness programs looking to offer a superior standard of care during this severe flu season and beyond, partnering with a trusted supplier of medical specimen collection products is essential. Huachenyang Technology’s VTM kits represent more than just a product; they are a critical enabler of a more resilient, responsive, and patient-centered diagnostic ecosystem.

The “super flu” season is a stark reminder that our approach to infectious disease management must evolve. By embracing the proven model of telemedicine-based diagnostics and supporting it with reliable, professional-grade at-home self-sampling kits, we can build a frontline defense that meets people where they are—safely, conveniently, and effectively.

A Viral Transport Medium (VTM) is a specialized liquid solution used to preserve and transport viral specimens (such as nasopharyngeal or oropharyngeal swabs) for laboratory testing. It maintains the viability and stability of viruses during transit, ensuring accurate diagnostic results.

Components of Viral Transport Medium:
Buffered Saline Solution – Maintains pH balance.

Protein Stabilizers (e.g., bovine serum albumin, gelatin) – Protect viral particles.

Antimicrobial Agents (e.g., gentamicin, amphotericin B) – Prevent bacterial/fungal growth.

Cryoprotectants (e.g., sucrose) – Helps in freezing/storage if needed.

Common Uses:
COVID-19 testing (SARS-CoV-2 detection)

Influenza (flu) testing

RSV (Respiratory Syncytial Virus) detection

Other respiratory or viral infections

Types of VTM:
Standard VTM – For routine transport at refrigerated temperatures (2–8°C).

Universal Transport Medium (UTM) – Compatible with multiple diagnostic methods (PCR, culture).

Molecular Transport Medium – Optimized for nucleic acid-based tests (like RT-PCR).

Storage & Handling:
Typically stored at room temperature or refrigerated.

Swabs should be placed in VTM immediately after collection.

Transported to the lab within 24–72 hours (or as per lab guidelines).

VTM ensures that viral samples remain stable until they reach the laboratory, improving the accuracy of diagnostic tests.

On June 26th, Huachenyang’s general specimen collection kit (virus transport media) was officially certified by UKCA, indicating that Huachenyang’s virus transport media meets the latest market access and conformity assessment requirements in the UK.

This also means that the quality and safety of Huachenyang’s products are officially certified and can be legally sold and used in the United Kingdom and countries and regions that recognize the UKCA registration, marking another important step for Huachenyang to enter the European market.

The Wide Use of General Specimen Collection Kit

• Used for monitoring and sampling of infectious pathogenic microorganisms by disease control departments and clinical departments.
• It is suitable for sampling influenza virus (common influenza, highly pathogenic avian influenza, H1N1 influenza virus, etc.), hand, foot, and mouth virus and other types of viruses.
• It is also used for sampling Mycoplasma, Chlamydia, Ureaplasma, etc.
• Used to transport nasopharyngeal swab specimens or tissue specimens of specific parts from the sampling site to the testing laboratory for PCR extraction and testing.
• It is used to preserve nasopharyngeal swab samples or tissue specimens of specific parts for necessary cell culture.

About UKCA

UKCA (United Kingdom Conformity Assessed) is a new product certification introduced after the UK’s exit from the European Union. Electrical and electronic products entering the UK market need to pass the standard tests under the UK regulations and obtain the UKCA certificate, and the products are marked with the UKCA logo to replace the EU CE marking in the UK market. Specific products such as automotive, aerospace, pharmaceutical products, medical devices, chemicals, and articles subject to national regulations (non-harmonized articles) will not be able to continue to use the EU norms and conformity marking when they are re-sold in the UK market after Brexit.